Smit, Pieter W.
Eggink, Dirk
Paltansing, Sunita
Hooiveld, Mariette
van Gageldonk-Lafeber, Arianne B.
Dunk, Djoo
Lekkerkerk, Sybren
Meijer, Adam
Funding for this research was provided by:
Maasstad ziekenhuis
Article History
Received: 24 September 2024
Accepted: 3 February 2025
First Online: 27 February 2025
Declarations
:
: The authors declare no competing interests.
: Non-WMO approval (WMO = Wet Medisch-wetenschappelijk Onderzoek met mensen; the Dutch law regulating medical scientific research with humans) was obtained at Maasstad hospital (L2024027) and Franciscus Gasthuis and Vlietland, Rotterdam the Netherlands (2024-031). For research based on data and samples collected in the GP sentinel surveillance a waiver for ethical approval was obtained from the Clinical Expert Centre RIVM (IDS-688). For Infectieradar a waiver for ethical approval was obtained from the Medical Ethics Review Committee Utrecht (reference number: WAG/avd/20/008757; protocol 20–131) given the nature of data collection. Due to the retrospective nature of the study, the Medical Ethics Review Committee Utrecht, the institutional review boards at Expert Centre RIVM, Maasstad hospital, and the institutional review board at Franciscus Gasthuis and Vlietland waived the need of obtaining informed consent. Hereby authors confirm that all experiments were performed in accordance with relevant guidelines and regulations that apply for this retrospective study on residual clinical samples.